European court rules off-label drugs compete with licensed drugs News item 10 February 2018 Pages: 2 - 2
Adalimumab dose escalation for UC treatment costly in Germany Clinical study 10 February 2018 Pages: 6 - 6
At-home naloxone cost effective in reversing heroin overdose Clinical study 10 February 2018 Pages: 7 - 7
Beta-lactam allergy worsens outcomes and increases costs Clinical study 10 February 2018 Pages: 8 - 8
Cost effectiveness of etelcalcetide versus cinacalcet in Europe Clinical study 10 February 2018 Pages: 9 - 9
Cost effectiveness of genetic testing in CRC uncertain Clinical study 10 February 2018 Pages: 10 - 10
DAAs cost effective for treatment of hepatitis C in Norway Clinical study 10 February 2018 Pages: 11 - 11
Diabetic complications impact healthcare costs in T2DM Clinical study 10 February 2018 Pages: 12 - 12
Economic burden of primary and recurrent C. difficile infection Clinical study 10 February 2018 Pages: 13 - 13
EPA plus statin cost effective for secondary prevention of CVD Clinical study 10 February 2018 Pages: 15 - 15
Haematopoietic stem cell transplantation cost effective Clinical study 10 February 2018 Pages: 17 - 17
Increased social spending would reduce mortality in Canada Clinical study 10 February 2018 Pages: 18 - 18
Making reimbursement decisions based on case series in Sweden Clinical study 10 February 2018 Pages: 19 - 19
Pan-Canadian Oncology Drug Review lacks full transparency Clinical study 10 February 2018 Pages: 23 - 23
PMC vaccines: better meningitis control at acceptable cost Clinical study 10 February 2018 Pages: 25 - 25
QIV cost effective versus TIV in South Africa and Vietnam Clinical study 10 February 2018 Pages: 26 - 26
Tranexamic acid cost effective in Nigeria and Pakistan Clinical study 10 February 2018 Pages: 29 - 29
Use of anti-cancer medicines "cause for concern" in Kosovo Clinical study 10 February 2018 Pages: 30 - 30